Biomolecular Network-Based Synergistic Drug Combination Discovery

Area of Science:

• Computational biology
• Systems biology
• Pharmacology

Background:

• Drug combinations are crucial for treating complex diseases like cancer but approved synergistic combinations are few.
• Existing predictive models for synergistic drug combinations have limitations.
• Biomolecular network-based models offer a systems-level view of drug-target-disease interactions.

Purpose of the Study:

• To review and classify biomolecular network-based models for synergistic drug combination prediction.
• To provide a comprehensive resource of databases and tools for synergistic drug combination discovery.
• To aid computational biologists in network medicine and drug design.

Main Methods:

• Systematic analysis and classification of synergistic drug combination prediction models based on algorithms.
• Literature review of recent advancements in the past decade.
• Compilation of relevant databases and computational tools.

Main Results:

• Categorization of various network-based algorithms for synergistic drug combination prediction.
• Identification of key databases and analysis tools facilitating drug discovery.
• Highlighting the advantages of network medicine approaches.

Conclusions:

• Biomolecular network models are effective for predicting synergistic drug combinations.
• This review serves as a valuable resource for researchers in computational biology and drug design.
• Advancing network-based approaches can accelerate the identification of novel combination therapies.